IP Library Granted Patent US 12,128,120
Granted Patent B2
US 12,128,120 · App. 18/217,568 · Granted Oct 29, 2024

Wound cleansing method

Inventor: Matthew F. Myntti (St. Augustine, FL)
Assignee: Next Science IP Holdings Pty Ltd
A61K8/498A01N25/02A01N25/08A01N25/30A01N37/36A01N41/04A01N59/00A01N59/26A01N61/00A61K8/19A61K8/34A61K8/347A61K8/365A61K8/37A61K8/39A61K8/41A61K8/416A61K8/44A61K8/463A61K8/466A61K8/4926A61K8/4973A61K8/55A61K8/602A61K8/86A61K9/0014A61K9/0063A61K9/06A61K31/14A61K31/19A61K31/194A61K33/00A61K33/02A61K33/04A61K33/20A61K33/24A61K33/32A61K33/42A61K47/02A61K47/10A61K47/12A61K47/34A61L26/0066A61P17/02A61P31/04A61Q11/00A61Q17/005A61K9/08A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,128,120
App. No.
18/217,568
Granted
Oct 29, 2024
Kind
B2
Abstract

An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment.

Claims (10)

1. A process for cleansing a surgical wound consisting of, prior to closure, introducing to said wound a liquid having a pH of from 2 to 4 and total solute concentration of from 1.8 to 2.8 Osm/L, said liquid being free of active antimicrobial agents and comprising as solutes one or more organic acids, at least one salt of said one or more organic acids, and from 0.9 to 1.7 g/L cationic surfactant.

2. The process of claim 1 wherein said cationic surfactant comprises benzalkonium chloride.

3. The process of claim 2 wherein said cationic surfactant is benzalkonium chloride.

4. The process of claim 1 wherein said one or more organic acids include citric acid.

5. The process of claim 4 wherein said at least one salt includes a salt of citric acid.

6. The process of claim 1 wherein said one or more organic acids is citric acid.

7. The process of claim 1 wherein said one or more organic acids include acetic acid.

8. The process of claim 7 wherein said at least one salt includes a salt of acetic acid.

9. The process of claim 1 wherein said one or more organic acids is acetic acid.

10. The process of claim 1 wherein the lower limit of said total solute concentration in said liquid is 2 Osm/L.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2025
From: NEXT SCIENCE IP HOLDINGS PTY LTD
To: OSARTIS GMBH
Reel/Frame 072590/0763 →
Continuity (7)
Continuation 17000348 · Aug 23, 2020
Continuation 16192100 · Nov 15, 2018
Continuation 15876181 · Jan 21, 2018
Continuation 14350322
Provisional Application 61660649 · Jun 15, 2012
Provisional Application 61545108 · Oct 8, 2011
Related Publication 20230338260A1 · Oct 26, 2023